Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1276273.RA1pt0GEv8PIqgTHaNxqzhNFIEt5VdD5B3Ybxpn7rLU6I130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1276273.RA1pt0GEv8PIqgTHaNxqzhNFIEt5VdD5B3Ybxpn7rLU6I130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1276273.RA1pt0GEv8PIqgTHaNxqzhNFIEt5VdD5B3Ybxpn7rLU6I130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1276273.RA1pt0GEv8PIqgTHaNxqzhNFIEt5VdD5B3Ybxpn7rLU6I130_provenance.
- NP1276273.RA1pt0GEv8PIqgTHaNxqzhNFIEt5VdD5B3Ybxpn7rLU6I130_assertion description "[Pharmacological or dominant-negative JNK inhibition restricts DLBCL survival in vitro and in vivo and synergizes strongly with the Bruton's tyrosine kinase inhibitor ibrutinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1276273.RA1pt0GEv8PIqgTHaNxqzhNFIEt5VdD5B3Ybxpn7rLU6I130_provenance.
- NP1276273.RA1pt0GEv8PIqgTHaNxqzhNFIEt5VdD5B3Ybxpn7rLU6I130_assertion evidence source_evidence_literature NP1276273.RA1pt0GEv8PIqgTHaNxqzhNFIEt5VdD5B3Ybxpn7rLU6I130_provenance.
- NP1276273.RA1pt0GEv8PIqgTHaNxqzhNFIEt5VdD5B3Ybxpn7rLU6I130_assertion SIO_000772 25847947 NP1276273.RA1pt0GEv8PIqgTHaNxqzhNFIEt5VdD5B3Ybxpn7rLU6I130_provenance.
- NP1276273.RA1pt0GEv8PIqgTHaNxqzhNFIEt5VdD5B3Ybxpn7rLU6I130_assertion wasDerivedFrom befree-2016 NP1276273.RA1pt0GEv8PIqgTHaNxqzhNFIEt5VdD5B3Ybxpn7rLU6I130_provenance.
- NP1276273.RA1pt0GEv8PIqgTHaNxqzhNFIEt5VdD5B3Ybxpn7rLU6I130_assertion wasGeneratedBy ECO_0000203 NP1276273.RA1pt0GEv8PIqgTHaNxqzhNFIEt5VdD5B3Ybxpn7rLU6I130_provenance.
- befree-2016 importedOn "2016-02-19" NP1276273.RA1pt0GEv8PIqgTHaNxqzhNFIEt5VdD5B3Ybxpn7rLU6I130_provenance.